B-Temia
B-Temia is a Quebec-based medical device company that develops AI-driven powered orthoses (dermoskeletons), primarily the Keeogo smart knee orthosis for mobility-impaired patients and the ONYX exoskeleton for military use, selling globally through regional distribution partners.
- Company typePrivate
- Founded2010
- HeadquartersSaint-augustin, Canada
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What B-Temia does
B-Temia Inc., founded in 2010 and headquartered in Quebec, Canada, develops and commercializes proprietary "dermoskeleton" technology — a class of powered orthoses that augment human mobility through embedded sensors, motorized joints, and proprietary AI-driven control software. Its flagship consumer and clinical product, Keeogo, is a smart powered knee orthosis designed for individuals with mobility limitations arising from conditions such as multiple sclerosis, osteoarthritis, Parkinson's disease, and post-stroke impairment. A parallel defense/industrial product line, ONYX, supplies powered exoskeletons to the U.S. Army via a 2018 partnership with Lockheed Martin.
The company's core technology combines wearable mechanical structures with an onboard computer that interprets user-initiated movement in real time and delivers assistive torque, enabling the device to augment rather than replace the wearer's natural gait. B-Temia has pursued a global, partner-led commercialization strategy: it holds Health Canada authorization, CE Mark (December 2019), FDA 510(k) clearance (September 2020), and TFDA approval (September 2020). Manufacturing and distribution are executed through a network of regional partners, including a Singapore-based joint venture with Wistron (B-Temia Asia Pte. Ltd., established November 2018) for Asian markets, Rebotics for the UK and France (2021), and Kuxtal for Mexico (2022). The company is privately held and operates with a headcount in the 11-50 range.
B-Temia's revenue model rests on hardware sales of Keeogo systems to clinical, rehabilitation, and individual end-user channels, complemented by defense contract revenue from ONYX. The Keeogo+ product refresh launched in September 2021 signals ongoing iteration on the consumer line. Leadership transitioned from founder Stéphane Bédard to David Quitman as CEO; Andy Hayes serves as Chief Medical Officer, and prior partnerships include Safran, indicating activity in aerospace and industrial adjacencies beyond the medical core.
B-Temia firmographics
Firmographics- Name
- B-Temia
- Legal name
- B-Temia Inc.
- Website
- https://b-temia.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- B-Temia is a Quebec-based medical device company that develops AI-driven powered orthoses (dermoskeletons), primarily the Keeogo smart knee orthosis for mobility-impaired patients and the ONYX exoskeleton for military use, selling globally through regional distribution partners.
- Ownership category
- akta.pro rank
B-Temia industry classification
Industry- Product category
- Wearable Medical Robotics / Powered Orthoses
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC)
- akta.pro secondary industries
- At-Home Medical Alert Sensors & Smart Home Safety Integrations (HSAHAHAJ), Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN)
Keywords
Where B-Temia is headquartered
LocationHeadquarters
- HQ city
- Saint-augustin
- HQ country
- Canada
- HQ region
- North America
Offices7 records
Markets served
B-Temia business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Keeogo Device Sales: Sale of Keeogo smart powered orthosis devices for rehabilitation and personal use. Approved for sale in Canada, Europe (CE marked), USA (FDA 510(k)), and Asia (Taiwan, Singapore, Hong Kong, Japan, Malaysia).
- Keeogo Rental: Device rental model available in Canada for personal assistive use, allowing customers to access the technology without full purchase.
- Military Exoskeleton Development: $6.9M USD agreement with U.S. Army NSRDEC and Lockheed Martin for optimization of ONYX exoskeleton technology for military field trials.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
B-Temia product offering
Product offeringCore offering
B-Temia designs, manufactures, and commercializes smart powered orthoses (exoskeletons) based on its proprietary Dermoskeleton technology, which combines robotics and AI to assist individuals with mobility impairments. Its flagship product, Keeogo, is a Smart Powered Knee Orthosis that detects, responds to, and supports the user's movements in rehabilitation, daily life, and occupational settings. The company also markets a military-grade variant, ONYX, developed with Lockheed Martin for the U.S. Army.
Product overview
B-Temia offers a product portfolio centered on its proprietary Dermoskeleton technology. The flagship product is Keeogo (and its improved version Keeogo+), a Smart Powered Knee Orthosis designed to assist individuals with mobility challenges including stroke, knee osteoarthritis, muscular or neurodegenerative conditions, and spinal cord injuries. Keeogo detects, responds and supports an individual's movements with AI-based software and motorized assistance. The company also developed the military variant ONYX in partnership with Lockheed Martin for the U.S. Army. All products share the core Dermoskeleton technology that provides strength and support while following the user's natural motion.
Differentiator
Problem solved
Functional benefit
Brands
- Keeogo: Smart Powered Knee Orthosis for people with mobility challenges, combining dermoskeleton technology with AI to assist gait and walking.
- Keeogo+
- Dermoskeleton
Products and services
- Keeogo Smart Powered Knee Orthosis that uses AI-based software and motorized assistance to detect, respond to, and support an individual's movements. Cues and improves gait quality for people with stroke, knee osteoarthritis, neurodegenerative, orthopedic, and other mobility-affecting conditions. CE approved for personal use and FDA/CE approved for professional rehabilitation use.
- Keeogo+ Improved version of the Keeogo smart powered knee orthosis with novel features for easy fit and intuitive configuration, designed to improve clinicians' efficiency and patient experience with better comfort and fitting capability.
- ONYX Exoskeleton Powered, lower-body exoskeleton adapted from B-Temia's Dermoskeleton technology for military use. Uses electro-mechanical knee actuators, a suite of sensors, and AI to learn user movements and deliver the right torque at the right time, assisting with walking inclines, lifting, or dragging heavy loads, and counteracting overstress on the lower back and legs.
Quantifiable outcome
- Keeogo demonstrated improvement in gait quality and patient/clinician safety in clinical study supporting FDA 510(k) submission
Companies that use B-Temia
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles4 records
B-Temia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
B-Temia partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- KUXTAL Bioingenieria S.A DE C.VcoreSince 2022, B-Temia has been collaborating with KUXTAL to commercialize Keeogo in Mexico. KUXTAL serves as the exclusive distributor for the Mexican market.
- Rebotics TechnologycoreSince 2021, B-Temia has been collaborating with Rebotics Technology to commercialize Keeogo in United Kingdom and France through ReBotic Technologies Ltd. and MediMex respectively.
- Lockheed Martincore$6.9M USD agreement (November 2018) with U.S. Army Natick Soldier Research, Development and Engineering Center (NSRDEC) with Lockheed Martin as prime contractor. B-Temia's dermoskeleton technology was adapted for military applications as the ONYX exoskeleton to protect soldiers from musculoskeletal injuries in hazardous environments. ONYX is co-branded under B-Temia Enabled trademark.
- B-Temia AsiacoreB-Temia Asia Pte. Ltd. incorporated as joint venture between Wistron Medical Technology Company and B-Temia Inc. in November 2018. Based in Singapore, it operates across Taiwan, China, Hong Kong, Japan, Malaysia, Thailand, Korea, and Singapore to commercialize B-Temia's medical products in Asia.
- JCMEHminorJoint venture marketing partner in China for Care & Rehabilitation Expo presence and market development activities alongside Wistron.
- Wistron CorporationcoreSince 2017, B-Temia has been closely collaborating with Wistron to manufacture and commercialize Keeogo in Asia. Wistron is one of the world's largest original design manufacturers (ODM) with revenues over CA$36 billion. In November 2018, B-Temia Asia Pte. Ltd. was incorporated as a joint venture to launch Keeogo in Asian markets. Wistron manufactures in ISO 13485 certified factories in Taiwan and China.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
B-Temia competitors and assessment
Company assessmentDirect peers
- Ekso Bionics: U.S. public company that develops and commercializes powered exoskeletons (Ekso GT) for stroke and spinal cord injury rehabilitation. Directly competes with Keeogo in hospital/clinic rehabilitation settings with FDA-cleared lower-limb exoskeletons.
- ReWalk Robotics: U.S./Israel public company offering the ReWalk Personal 6.0 exoskeleton for spinal cord injury and the ReStore soft exosuit for stroke rehabilitation. Competes with B-Temia in powered orthosis/exoskeleton rehab and personal mobility.
- Cyberdyne: Japan-based developer of the HAL (Hybrid Assistive Limb) lower-limb powered exoskeleton, one of the most established wearable robotics products globally with regulatory approvals across Asia and Europe. Directly comparable technology and target users to Keeogo.
- Wandercraft: French robotics company developing Atalante, a self-balancing lower-limb exoskeleton for personal mobility in paraplegic and stroke patients. Directly comparable in product category, customer segment, and AI-driven control approach.
- Parker Hannifin (Indego): Parker Hannifin's Indego is a modular powered exoskeleton for clinical and personal use by individuals with spinal cord injury. Direct competitor to Keeogo in the powered orthosis rehab category with FDA-cleared and CE-marked products.
Broad incumbents
- Ottobock: Global German prosthetics/orthotics leader (acquired SuitX and Hocoma) with broad DME portfolio including exoskeletons (Paexo) and rehab robotics (Lokomat). Competes with B-Temia across multiple mobility and rehab product lines as a much larger established incumbent.
- Össur: Iceland-based global leader in prosthetics and orthotics, having previously commercialized the POWER KNEE (originating from B-Temia founder's earlier Victhom venture). Comparable as a powered orthotics competitor with established rehab channel and broader product portfolio.
Emerging players
- Human in Motion Robotics: Canadian competitor developing the XoMotion lower-limb exoskeleton for spinal cord injury and stroke rehabilitation. Direct product overlap with Keeogo and headquartered in the same Canadian ecosystem, making it a relevant emerging peer.
- Trexo Robotics: Canadian startup building pediatric wearable robotic gait trainers. Adjacent technology and customer overlap with B-Temia's rehabilitation mobility focus, though Trexo targets the pediatric segment specifically.
Others
- Lockheed Martin (ONYX partner): U.S. defense prime contractor and B-Temia's 2018 $6.9M ONYX co-development partner for U.S. Army NSRDEC. Listed as a peer because it is both a strategic customer/partner and a potential competitor for military exoskeleton procurement programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
B-Temia social profiles
Digital presenceB-Temia compliance and trust
Trust signalCompliance4 records
B-Temia financial estimates
Financial estimateRevenue estimate
Valuation estimate
B-Temia leadership team
Management profileNumber of profiles
Profiles4 records
B-Temia subsidiaries and ownership
Company hierarchySubsidiaries3 records
B-Temia funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
B-Temia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about B-Temia
What does B-Temia do?
B-Temia designs, manufactures, and commercializes smart powered orthoses (exoskeletons) based on its proprietary Dermoskeleton technology, which combines robotics and AI to assist individuals with mobility impairments. Its flagship product, Keeogo, is a Smart Powered Knee Orthosis that detects, responds to, and supports the user's movements in rehabilitation, daily life, and occupational settings. The company also markets a military-grade variant, ONYX, developed with Lockheed Martin for the U.S. Army.
Is B-Temia a public or private company?
B-Temia is a private company. It is classified as venture growth investor backed and is currently operating.
When was B-Temia founded?
B-Temia was founded in 2010. It employs 11 to 50 people.
Where is B-Temia based?
B-Temia is headquartered in Saint-augustin, Canada, in the North America region.
How does B-Temia make money?
Three revenue lines are on record. Keeogo Device Sales are the primary driver. The others are keeogo Rental and military Exoskeleton Development.
Who are B-Temia's main competitors?
Direct peers on record are Ekso Bionics, ReWalk Robotics, Cyberdyne, Wandercraft and Parker Hannifin (Indego). Broad incumbents are Ottobock and Össur. Emerging players are Human in Motion Robotics and Trexo Robotics. Lockheed Martin (ONYX partner) is listed as an others.
Does B-Temia have an API?
No public API is recorded for B-Temia.
What industry is B-Temia in?
B-Temia's product category is Wearable Medical Robotics / Powered Orthoses. Its primary akta.pro industry code is HLAHAMAC, Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports), with a secondary code of HSAHAHAJ, At-Home Medical Alert Sensors & Smart Home Safety Integrations. Its NAICS code is 339113 and its SIC code is 3842.